Arcellx Inc’s recent filing unveils that its Director Ware Olivia C unloaded Company’s shares for reported $0.52 million on Apr 16 ’24. In the deal valued at $55.55 per share,9,402 shares were sold. As a result of this transaction, Ware Olivia C now holds 0 shares worth roughly $ 0.0.
Then, Elghandour Rami sold 23,086 shares, generating $1,548,887 in total proceeds. Upon selling the shares at $67.09, the insider now owns 69,253 shares.
Before that, Heery Christopher sold 5,450 shares. Arcellx Inc shares valued at $376,648 were divested by the CHIEF MEDICAL OFFICER at a price of $69.11 per share. As a result of the transaction, Heery Christopher now holds 8,938 shares, worth roughly $0.46 million.
Morgan Stanley initiated its Arcellx Inc [ACLX] rating to an Overweight in a research note published on March 07, 2024; the price target was $81. A number of analysts have revised their coverage, including Needham’s analysts, who remained covering the stock and in early January has reiterated a ‘”a Buy”‘ rating for it. Scotiabank began covering ACLX with “Sector outperform” recommendation on December 19, 2023. TD Cowen started covering the stock on October 30, 2023. It rated ACLX as “an Outperform”.
Price Performance Review of ACLX
On Friday, Arcellx Inc [NASDAQ:ACLX] saw its stock fall -5.23% to $51.65. Over the last five days, the stock has lost -11.06%. Arcellx Inc shares have fallen nearly -6.94% since the year began. Nevertheless, the stocks have risen 46.48% over the past one year. While a 52-week high of $75.10 was reached on 03/07/24, a 52-week low of $30.74 was recorded on 04/19/24. SMA at 50 days reached $64.87, while 200 days put it at $48.54. A total of 0.74 million shares were traded, compared to the trading of 0.69 million shares in the previous session.
Levels Of Support And Resistance For ACLX Stock
The 24-hour chart illustrates a support level at 50.08, which if violated will result in even more drops to 48.51. On the upside, there is a resistance level at 54.17. A further resistance level may holdings at 56.69. The Relative Strength Index (RSI) on the 14-day chart is 25.20, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -5.50, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 95.90%. Stochastics %K at 5.76% indicates the stock is a buying.
The most recent change occurred on October 17, 2023 when UBS began covering the stock and recommended ‘”a Buy”‘ rating along with a $52 price target.
